ClinVar Miner

Submissions for variant NM_001378454.1(ALMS1):c.9712C>T (p.Arg3238Cys) (rs201252375)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001082321 SCV000541330 likely benign Alstrom syndrome 2020-12-06 criteria provided, single submitter clinical testing
GeneDx RCV000520369 SCV000618206 likely benign not provided 2020-09-08 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001269158 SCV001448426 uncertain significance not specified 2020-11-09 criteria provided, single submitter clinical testing Variant summary: ALMS1 c.9709C>T (p.Arg3237Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00059 in 249464 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in ALMS1 causing Alstrom Syndrome (0.00059 vs 0.0014), allowing no conclusion about variant significance. c.9709C>T has been reported in the literature in individuals affected with Alstrom Syndrome or Very Early Onset Atrial Fibrillation (Zmyslowska_2016, Goodyer_2019). These reports do not provide unequivocal conclusions about association of the variant with Alstrom Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Based on the evidence outlined above, the variant was classified as uncertain significance.
Stanford Center for Inherited Cardiovascular Disease, Stanford University RCV000520369 SCV000924728 uncertain significance not provided 2017-05-02 no assertion criteria provided provider interpretation p.Arg3239Cys (c.9715C>T) in exon 11 of the ALMS1 gene (NM_015120.4) Chromosome position: 2:73747074 C / T Based on the information reviewed below, including this variant’s relatively high frequency in the Ashkenazi Jewish population (MAF=0.73%), coupled with poor conservation at this residue across evolution (several species have Cysteine as the default amino acid), we classify it as a Variant of Uncertain Significance, Probably Benign, concluding that there is not sufficient evidence for its pathogenicity to warrant using it for predictive genetic testing. The ALMS1 gene is associated with autosomal recessive Alstrom syndrome (MedGen UID: 78675). For this reason, any one heterozygous variant is an unlikely explanation for disease, although it cannot be ruled out. This variant has not been reported in the literature in association with disease. It has been reported to ClinVar only by Invitae as of 4/29/2017. This is a non-conservative amino acid change, resulting in the replacement of a positively-charged Arginine with a polar Cysteine that it capable of forming disulfide bridges. Arginine at this location is very poorly conserved across vertebrate species. In fact, Cysteine is the default amino acid in at least 3 species. According to the Invitae report, algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). There are no Likely Pathogenic or Pathogenic variants listed within 10 amino acids of this residue in ClinVar as of 4/29/2017. Most Pathogenic variants in ALMS1 listed in ClinVar are truncating (frameshift or nonsense) and not missense like this one. This particular transcript for ALMS1 is not found in gnomAD. However, there is an Arg3237Cys variant in gnomAD (rs201252375) that appears to be the same thing. It has been reported in 170 individuals in the gnomAD database, which includes variant calls on ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. Overall MAF: 0.06%. Specifically, the variant was observed in 74/5,075 Ashkenazi Jews (for the highest allele frequency: 0.73%), 81/63,302 non-Finnish Europeans, 6 Finnish Europeans, 6 Other, 2 Latinos, and 1 South Asian. Our patient’s ancestry is from Belarus and Ukraine. The phenotype of the individuals in gnomAD is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases.
Natera, Inc. RCV001082321 SCV001459592 likely benign Alstrom syndrome 2020-06-05 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.